Journal Article DZNE-2024-01180

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Circadian rhythm of brain-derived neurotrophic factor in serum and plasma.

 ;  ;  ;  ;  ;  ;  ;  ;

2024
Wiley-Blackwell Oxford [u.a.]

Experimental physiology 109(10), 1755 - 1767 () [10.1113/EP091671]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The neurotrophic growth factor brain-derived neurotrophic factor (BDNF) plays a crucial role in various neurodegenerative and psychiatric diseases, such as Alzheimer's disease, schizophrenia and depression. BDNF has been proposed as a potential biomarker for diagnosis, prognosis and monitoring therapy. Understanding the factors influencing BDNF levels and whether they follow a circadian rhythm is essential for interpreting fluctuations in BDNF measurements. We aimed to investigate the circadian rhythm of BDNF by collecting multiple peripheral venous blood samples from young, healthy male participants at 12 different time points over 24 h. In addition, vital parameters, cortisol and insulin like growth factor 1 (IGF1) were measured to explore potential regulatory mechanisms, interfering variables and their correlations with BDNF concentration. The findings revealed that plasma BDNF did not exhibit any significant fluctuations over 24 h, suggesting the absence of a circadian rhythm. However, serum BDNF levels decreased during sleep. Furthermore, serum BDNF showed a positive correlation with heart rate but a negative correlation with IGF1. No significant correlation was observed between cortisol and BDNF or IGF1. Although plasma BDNF suggests steady-state conditions, the decline of serum BDNF during the nocturnal period could be attributed to physical inactivity and associated with reduced haemodynamic blood flow (heart rate reduction during sleep). The type of sample collection (peripheral venous cannula vs. blood sampling using a butterfly system) does not significantly affect the measured BDNF levels. The sample collection during the day did not significantly affect BDNF analysis, emphasizing the importance of considering activity levels rather than timing when designing standardized protocols for BDNF assessments.

Keyword(s): Humans (MeSH) ; Male (MeSH) ; Brain-Derived Neurotrophic Factor: blood (MeSH) ; Circadian Rhythm: physiology (MeSH) ; Hydrocortisone: blood (MeSH) ; Insulin-Like Growth Factor I: metabolism (MeSH) ; Adult (MeSH) ; Young Adult (MeSH) ; Heart Rate: physiology (MeSH) ; Sleep: physiology (MeSH) ; biomarker ; brain‐derived neurotrophic factor ; circadian rhythm ; sleep ; Brain-Derived Neurotrophic Factor ; Hydrocortisone ; Insulin-Like Growth Factor I ; BDNF protein, human ; IGF1 protein, human

Classification:

Contributing Institute(s):
  1. Neuroprotection (AG Müller)
  2. Mixed Cerebral Pathologies and Cognitive Aging (AG Schreiber)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2024
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > MD DZNE > MD DZNE-AG Schreiber
Institute Collections > MD DZNE > MD DZNE-AG Müller
Full Text Collection
Public records
Publications Database

 Record created 2024-10-02, last modified 2025-01-27


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)